ACOR

Acorda Therapeutics

Delisted

ACOR was delisted on the 11th of April, 2024.

167 hedge funds and large institutions have $1.01B invested in Acorda Therapeutics in 2016 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 58 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
167
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14.5M
Puts
$21.5M
Net Calls
Net Calls Change

Top Buyers

1 +$21.6M
2 +$12.6M
3 +$11.4M
4
Citadel Advisors
Citadel Advisors
Florida
+$9.62M
5
Goldman Sachs
Goldman Sachs
New York
+$9.02M

Top Sellers

1 -$18.1M
2 -$11.5M
3 -$7.83M
4
Prudential Financial
Prudential Financial
New Jersey
-$7.03M
5
Millennium Management
Millennium Management
New York
-$6.63M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$262K
127
$242K
128
$233K
129
$228K
130
$221K
131
$213K
132
$209K
133
$198K
134
$196K
135
$190K
136
$188K
137
$172K
138
$153K
139
$142K
140
$122K
141
$96K
142
$89.8K
143
$74K
144
$71K
145
$69K
146
$58K
147
$40K
148
$31K
149
$26K
150
$22K